Scalmibio: An oncology biotech (antibody prodrugs) startup from idea to exit that originated from the founder's own fight with cancer episode artwork

EPISODE · Dec 14, 2021 · 1H 22M

Scalmibio: An oncology biotech (antibody prodrugs) startup from idea to exit that originated from the founder's own fight with cancer

from Lab to Startup

Summary: Marija Vrljic, Ph.D., is the co-founder and CEO of Scalmibio, an early-stage biotechnology startup that developed a transformational technology focused on oncology applications. We talk about the inspiration for launching the startup, how she was able to bootstrap the company, raised non-dilutive funds which ultimately led to being acquired in October, 2020. Show notes: - ScalmiBio is a startup that was born when Marija was diagnosed with thyroid cancer - Technology: Antibody prodrugs that could target only cancer tissues and remain inactive around healthy tissues. - Startup was based on unique insights (around protein folding and publicly available protein databases) that came from deep understanding of work during graduate and postdoctoral research. - Founding story - Bar for founding a startup for scientists with data packages from their research is much lower. In terms of fundability- In vivo model as a proof of concept seems to be more fundable for life sciences startups. - SBIR/STTR funding Small Business Transition Grant For Early Career Scientist: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-21-001.html NCI SBIR Concept Award https://sbir.cancer.gov/funding/concept NCI SBIR writing assistance program: https://sbir.cancer.gov/programseducation/aap?cid=eb_govdel - Writing out a grant gives clarity and helps builds a business case - The whole scientific field would say that the technology might not work because there was not enough data - Talking to folks (once you filed provisional patent) in the industry usually helps entrepreneurs understand potential issues on both the technology and business fronts. - You need to have a lead product before talking about platform plays - Raising VC funds to take a product to the market might not always be the fastest way. Working as a part of a bigger company with the right resources - Recruited by Pat Brown as one of the first scientists to work at Impossible Foods - Understanding the concept of scaling and costs/pricing is super important as you embark on the startup journey - It is hard to stay competitive- You have to move fast and get better results than the competition - Network with engineers, law students, MBA students and others while in grad school/postdoc- a valuable skill!   Startup Pitch ubiqd.com Email: Hunter McDaniel- [email protected]

Episode metadata supplied by the publisher feed · Published Dec 14, 2021

Embed this episode

NOW PLAYING

Scalmibio: An oncology biotech (antibody prodrugs) startup from idea to exit that originated from the founder's own fight with cancer

0:00 1:22:15

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Lab to Startup?

This episode is 1 hour and 22 minutes long.

When was this Lab to Startup episode published?

This episode was published on December 14, 2021.

Can I download this Lab to Startup episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!